←Back to structures
S2_012_000_R2_scaffold_0_prodigal-single.1__X__X__00433
Bact-VirS2_012_000_R2_scaffold_0_prodigal-single.1__X__X__00433
3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 18-71
Domain cluster:
rep: Salt_Pond_R2_restored_H2O_MG_scaffold_3_prodigal-single.1__X__X__00391__D54-111
CATH (22)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 2dloA00 | 2.10.110.10 | Mainly Beta › Ribbon › Cysteine Rich Protein › Cysteine Rich Protein | 0.74 | 52.0 | 4.54e-01 | 79.6% | 49.4% |
| 2bayE00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.66 | 54.0 | 5.31e-01 | 90.7% | 86.4% |
| 8eb0A01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.66 | 56.0 | 4.89e-01 | 100.0% | 82.6% |
| 1wgmA01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.65 | 51.0 | 4.74e-01 | 94.4% | 67.1% |
| 3knvA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.65 | 52.0 | 3.99e-01 | 88.9% | 49.6% |
| 2yvrA00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.65 | 43.0 | 4.62e-01 | 88.9% | 84.4% |
| 3ddtC00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.64 | 44.0 | 4.70e-01 | 88.9% | 88.6% |
| 5d1kB01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.64 | 53.0 | 4.82e-01 | 96.3% | 83.1% |
| 2ffwA00 | 4.10.830.40 | Few Secondary Structures › Irregular › 30s Ribosomal Protein S14; Chain N › | 0.64 | 49.0 | 4.37e-01 | 88.9% | 59.0% |
| 2csyA01 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.61 | 47.0 | 4.64e-01 | 88.9% | 83.3% |
| 2dsmA00 | 3.30.40.30 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › YqaI domain | 0.61 | 41.0 | 3.83e-01 | 85.2% | 54.2% |
| 2yu4A00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.60 | 50.0 | 4.23e-01 | 96.3% | 62.8% |
| 1z6uA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.58 | 45.0 | 3.64e-01 | 90.7% | 46.1% |
| 2csvA00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.57 | 49.0 | 4.44e-01 | 94.4% | 75.0% |
| 5d0iB00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.56 | 45.0 | 4.58e-01 | 100.0% | 98.0% |
| 2vp7A00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.55 | 41.0 | 3.89e-01 | 100.0% | 66.7% |
| 2lvhA00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.55 | 37.0 | 3.93e-01 | 96.3% | 84.4% |
| 1vb3A02 | 3.40.50.1100 | Alpha Beta › 3-Layer(aba) Sandwich › Rossmann fold › | 0.54 | 45.0 | 3.16e-01 | 100.0% | 59.7% |
| 3okqA00 | 1.20.58.1540 | Mainly Alpha › Up-down Bundle › Methane Monooxygenase Hydroxylase; Chain G, domain 1 › Actin interacting protein 3, C-terminal domain | 0.54 | 35.0 | 2.69e-01 | 77.8% | 27.2% |
| 2ma5A00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.52 | 39.0 | 3.78e-01 | 94.4% | 73.8% |
| 1x3cA00 | 3.30.160.60 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Classic Zinc Finger | 0.51 | 35.0 | 3.26e-01 | 81.5% | 54.8% |
| 1wemA00 | 3.30.40.10 | Alpha Beta › 2-Layer Sandwich › Herpes Virus-1 › Zinc/RING finger domain, C3HC4 (zinc finger) | 0.51 | 40.0 | 3.61e-01 | 100.0% | 63.2% |
ECOD (52)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3729281 | 377.1.1.93 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › Paired_CXXCH_1 | 0.80 | 50.0 | 6.10e-01 | 70.4% | 100.0% |
| 3670642 | 904.1.1.1 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › zf-B_box | 0.79 | 59.0 | 5.54e-01 | 88.9% | 66.2% |
| 3890045 | 904.1.1.3 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › ANCHR-like_BBOX | 0.76 | 55.0 | 5.90e-01 | 85.2% | 93.3% |
| 3529691 | 904.1.1.0 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain | 0.75 | 56.0 | 6.06e-01 | 88.9% | 97.8% |
| 3558133 | 377.1.1.5 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › LIM | 0.75 | 51.0 | 4.83e-01 | 72.2% | 61.5% |
| 4547414 | 377.1.1.5 ↗ | few secondary structure elements › Glucocorticoid receptor-like › LIM domain-like › LIM domain-like › LIM | 0.73 | 54.0 | 5.83e-01 | 77.8% | 93.3% |
| 3871698 | 904.1.1.6 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain › PML_CC | 0.71 | 52.0 | 4.34e-01 | 88.9% | 44.2% |
| 3928741 | 376.1.1.27 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_5 | 0.70 | 62.0 | 5.34e-01 | 100.0% | 81.2% |
| 4853380 | 376.1.1.35 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_14 | 0.70 | 54.0 | 4.69e-01 | 85.2% | 62.4% |
| 3247175 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.69 | 59.0 | 5.27e-01 | 100.0% | 95.0% |
| 3561651 | 376.1.1.27 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_5 | 0.69 | 56.0 | 5.20e-01 | 90.7% | 81.4% |
| 4011231 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.68 | 59.0 | 5.26e-01 | 100.0% | 85.0% |
| 3796293 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.68 | 49.0 | 4.74e-01 | 75.9% | 73.3% |
| 3829583 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.68 | 59.0 | 5.23e-01 | 100.0% | 95.0% |
| 3411064 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.68 | 55.0 | 5.73e-01 | 88.9% | 98.0% |
| 4026153 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 52.0 | 4.95e-01 | 87.0% | 78.5% |
| 3805637 | 376.1.1.61 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Rtf2 | 0.66 | 53.0 | 4.67e-01 | 88.9% | 68.8% |
| 3743942 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 53.0 | 4.53e-01 | 90.7% | 58.9% |
| 3724405 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 57.0 | 5.05e-01 | 100.0% | 85.0% |
| 3601028 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 53.0 | 5.16e-01 | 90.7% | 93.3% |
| 4025773 | 376.1.1.32 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-UBP_var | 0.66 | 54.0 | 4.39e-01 | 98.1% | 60.9% |
| 3593825 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 53.0 | 4.62e-01 | 90.7% | 76.5% |
| 3399231 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.66 | 51.0 | 4.63e-01 | 87.0% | 97.3% |
| 3173230 | 376.1.1.32 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-UBP_var | 0.65 | 53.0 | 4.27e-01 | 98.1% | 66.7% |
| 3249848 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.65 | 55.0 | 4.86e-01 | 100.0% | 88.2% |
| 3743358 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.65 | 51.0 | 5.01e-01 | 88.9% | 95.0% |
| 3503755 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.65 | 51.0 | 5.01e-01 | 88.9% | 98.3% |
| 3206375 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.64 | 49.0 | 4.94e-01 | 85.2% | 87.3% |
| 3620492 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.64 | 47.0 | 4.90e-01 | 75.9% | 82.0% |
| 3507545 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.64 | 51.0 | 4.60e-01 | 88.9% | 84.0% |
| 3858618 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.64 | 53.0 | 4.72e-01 | 96.3% | 80.0% |
| 3622713 | 376.1.1.78 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Zf_2nd_IFT121 | 0.64 | 50.0 | 4.22e-01 | 88.9% | 54.7% |
| 3990940 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.63 | 50.0 | 4.60e-01 | 90.7% | 100.0% |
| 3237486 | 376.1.1.20 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_UBOX | 0.62 | 53.0 | 5.05e-01 | 98.1% | 98.5% |
| 3927096 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.62 | 49.0 | 4.41e-01 | 90.7% | 70.0% |
| 3170592 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.62 | 47.0 | 4.46e-01 | 85.2% | 89.2% |
| 3760308 | 904.1.1.0 ↗ | few secondary structure elements › B-box zinc-binding domain-like › B-box zinc-binding domain › B-box zinc-binding domain | 0.62 | 48.0 | 4.83e-01 | 88.9% | 87.3% |
| 3722098 | 376.1.1.61 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Rtf2 | 0.61 | 48.0 | 4.60e-01 | 88.9% | 83.1% |
| 3859003 | 376.1.1.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-C3HC4 | 0.60 | 51.0 | 4.40e-01 | 98.1% | 73.3% |
| 3793771 | 376.1.1.15 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-Nse | 0.60 | 50.0 | 4.36e-01 | 96.3% | 69.3% |
| 3225801 | 376.1.1.27 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_5 | 0.60 | 49.0 | 3.56e-01 | 90.7% | 34.7% |
| 3693687 | 379.1.1.0 ↗ | few secondary structure elements › Kazal-type serine protease inhibitors-like › Kazal-type serine protease inhibitors › Kazal-type serine protease inhibitors | 0.60 | 45.0 | 4.33e-01 | 87.0% | 89.2% |
| 3782574 | 376.1.1.61 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › Rtf2 | 0.60 | 49.0 | 4.58e-01 | 94.4% | 80.0% |
| 3211190 | 376.1.1.27 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_5 | 0.60 | 48.0 | 4.57e-01 | 90.7% | 76.9% |
| 3384566 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.59 | 45.0 | 4.30e-01 | 85.2% | 86.2% |
| 4364548 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.59 | 50.0 | 4.53e-01 | 98.1% | 76.0% |
| 3392386 | 376.1.1.21 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box › zf-RING_2 | 0.59 | 46.0 | 4.44e-01 | 90.7% | 86.2% |
| 3177802 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.58 | 43.0 | 4.37e-01 | 87.0% | 81.8% |
| 3452589 | 376.1.3.1 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › FYVE/PHD zinc finger › PHD | 0.57 | 41.0 | 4.10e-01 | 94.4% | 78.2% |
| 5060499 | 376.1.1.0 ↗ | few secondary structure elements › RING/U-box-like › RING/U-box-like › RING/U-box | 0.55 | 42.0 | 4.20e-01 | 96.3% | 87.3% |
| 3616359 | 386.1.1.0 ↗ | few secondary structure elements › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers › beta-beta-alpha zinc fingers | 0.54 | 36.0 | 3.32e-01 | 72.2% | 53.8% |
| 3723089 | 323.1.1.3 ↗ | a+b complex topology › CoA-dependent acyltransferases › CoA-dependent acyltransferases › CoA-dependent acyltransferases › AMP-binding | 0.51 | 37.0 | 2.72e-01 | 83.3% | 40.6% |